Press Releases

Share
and/or
488 News Releases found
Robert Daly and Bob Li
Nature Medicine Commentary Outlines Global Collaboration in Reimagining Patient-Centric Cancer Clinical Trials
A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials. The piece was published in the April 19, 2022, “The Future of Cancer Research” special Focus edition of the journal Nature Medicine.
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science
Memorial Sloan Kettering Cancer Center Announces The Starr Foundation Program for Discovery Science
Memorial Sloan Kettering Cancer Center (MSK) today announced the establishment of The Starr Foundation Program for Discovery Science, a pioneering new initiative made possible by a generous $50 million gift from The Starr Foundation. The program will support the visionary work of scientists at the Sloan Kettering Institute (SKI), the research arm of MSK, by funding foundational laboratory research that will drive the next generation of cancer breakthroughs and ultimately improve the lives of people facing cancer around the world.
Memorial Sloan Kettering Applauds NYS Budget For Expanding Access to Cancer Care
Memorial Sloan Kettering Applauds NYS Budget For Expanding Access to Cancer Care
Last week, Governor Kathy Hochul signed the New York State Budget for FY 2023 that includes a key provision which will allow more New Yorkers from underserved communities access to care at Memorial Sloan Kettering Cancer Center (MSK) and other NCI-designated cancer centers in the state.
Luis Alberto Diaz Jr., MD; Christine Iacobuzio-Donahue, MD, PhD; and Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center Experts to Present Notable Work at the American Association for Cancer Research 2022 Annual Meeting
Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the American Association for Cancer Research (AACR) Annual Meeting on April 8-13 in New Orleans, La.
Graphic text that reads Healthcare Equity Index LGBTQ+ Healthcare Equality Leader
MSK Recognized for Commitment to LGBTQ+ Community
MSK has been recognized as an LGBTQ+ Healthcare Equality Leader, once again receiving a maximum overall score of 100 from the Human Rights Campaign Foundation on its 2022 Healthcare Equity Index (HEI).
Fumiko Chino, Craig B. Thompson, and Jedd D. Wolchok
Fumiko Chino, Craig B. Thompson, and Jedd D. Wolchok Awarded the Highest Honors From the American Society of Clinical Oncology (ASCO)
These special awards are presented to researchers and global oncology leaders who have reshaped cancer care around the world and are among the highest honors bestowed by ASCO.
Drs. Diaz Jr., Kelly, Pavletich, Rosen, and Rudensky.
Five Memorial Sloan Kettering Cancer Center Scientific Luminaries Elected as Fellows of the American Association for Cancer Research (AACR) Academy
Five Memorial Sloan Kettering (MSK) faculty were named today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy Class of 2022.
Advanced Practice Providers (APP) nurse practitioner Amy Devigne and a lung cancer survivor
Memorial Sloan Kettering Plans New Pavilion to Ensure Greater Access to Care for All People in New York and Beyond
To ensure greater access to cancer care for all New Yorkers and patients who come from around the globe, Memorial Sloan Kettering Cancer Center (MSK) today announced plans to build a new, state-of-the-art cancer care Pavilion on its main campus on the Upper East Side.
MSK Awards & Appointments March 2022
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
MSK Awards & Appointments February 2022
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Marie-Josée and Henry R. Kravis
Memorial Sloan Kettering Announces $100M Gift to Create The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project to Spur the Next Generation of Pre-Clinical Cancer Research
Memorial Sloan Kettering Cancer Center (MSK) today announced the creation of The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project to spur the next revolution of pre-clinical research, discovery, and treatment.
Memorial Sloan Kettering President and CEO Craig B. Thompson, MD
Memorial Sloan Kettering President and CEO Craig B. Thompson, MD to Step Down
Craig B. Thompson announced his intention to step down as President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center and has asked the Boards of Trustees and Governing Trustees to begin a search for his successor.
Nikolaus Schultz, PhD
Pivotal Memorial Sloan Kettering Cancer Center Study Provides Insights into the Genomic Basis of Cancer Metastasis
A new study from Memorial Sloan Kettering Cancer Center (MSK) provides important insights into cancer metastasis.  
Ghassan Abou-Alfa, MD
Immunotherapy Combination Significantly Improves Overall Survival for People with Advanced Liver Cancer Compared with Current Standard of Care
New study results found that patients who received a combination of the immunotherapy drugs durvalumab and tremelimumab significantly improved overall survival
MSK Awards & Appointments January 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Rémy Evard
Memorial Sloan Kettering Cancer Center Appoints Rémy Evard as Chief Digital Officer and Head of Technology
Memorial Sloan Kettering Cancer Center (MSK) today announced that Rémy Evard has joined as its new Chief Digital Officer and Head of Technology.
Fiona and Stanley Druckenmiller
Memorial Sloan Kettering Cancer Center Announces the Creation of the Fiona and Stanley Druckenmiller Presidential Innovation Fund
Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.
MSK Awards & Appointments December 2021
Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.
Gilles Salles
MSK Chief of the Lymphoma Service Gilles Salles Presents Promising New Treatment for Patients with Diffuse Large B-Cell Lymphoma
The research was published in the New England Journal of Medicine and presented at the American Society of Hematology (ASH) Annual Meeting and Exposition.
Andrea Barrio, MD
MSK Experts Shine a Light on the Impact of Race and Ethnicity on Breast Cancer Related Lymphedema
Researchers found that Black race was the strongest predictor of lymphedema development with a 3.5-fold increased incidence of lymphedema in Black women compared to White women.